What Is Standing in the Gaap?

What Is Standing in the Gaap?

Celgene has created the “Standing in the Gaap for African Americans with Multiple Myeloma” initiative to help spread the word about how multiple myeloma affects African Americans differently, in order to improve the quality of the care they receive.

KEY POINTS

  1. Standing in the Gaap: An initiative created to help bridge the gaps in care for African Americans living with multiple myeloma
  2. The essence of the phrase “Standing in the Gap” is: I am there for you, I have your back, I will provide the bridge to help you achieve your goals

Stand in the Gaap for African Americans With Multiple Myeloma

Multiple myeloma is the second most common form of blood cancer in the United States, and the most common blood cancer among African Americans, yet it is still relatively rare. It affected about 90,000 Americans, including about 18,000 African Americans, in 2012. The good news is that some studies suggest that compared to white Americans, African Americans tend to have less aggressive forms of multiple myeloma and may have a better prognosis when receiving the proper care. This means that when African Americans get the care they need, they may be able to live longer with the disease. However, data suggest that African Americans with multiple myeloma aren’t always getting the appropriate care they need.

Join Us In Standing in the Gaap

The Standing in the Gaap initiative offers information and resources to help you feel more confident and involved in your care. Get informed, find out about support available to you, and work with your doctors and nurses to get the best care possible.

Download the Standing in the Gaap brochure to learn more about multiple myeloma and how the disease could affect you differently.

Standing in the Gaap Brochure

Was this helpful?

Brought to you by Celgene Corporation. | Intended for a US audience.